Bimatoprost Ophthalmic Solution, 0.01%
MW230021
Phase 1 small_molecule active
Quick answer
Bimatoprost Ophthalmic Solution, 0.01% for Open-angle Glaucoma is a Phase 1 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Open-angle Glaucoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active